PATENT CLAIM ANALYSIS

Application Number: 16329336
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "365000"]

Abstract:
The invention describes an aryl-2,2′-tandem bisthiazole compound and a preparation method and the use thereof. In particular, disclosed in the present invention are an aryl-2,2′-tandem bisthiazole compound with the structure as shown in general formula I and the preparation method thereof and use thereof as a histone deacetylase inhibitor in the preparation of antitumor drugs.

Claim (Index 13):
A method of  claim 12 , wherein the tumor cells are multiple myeloma cells, colon cancer cells, lung cancer cells, embryo lung cells, liver cancer cells, breast cancer cells, ovarian cancer cells, pancreatic cancer cells, rectal cancer cells, gastric cancer cells, lymphoma cells or leukemia cells; and the tumor is multiple myeloma, colon cancer, lung cancer, liver cancer, breast cancer, ovarian cancer, pancreatic cancer, rectal cancer, gastric cancer, lymphoma, or leukemia.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 99.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14391386', '16078054', '12734026', '14361548', '10594483']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7923018140055806
- 35 USC 102 Novelty (BERT): 0.515605921026509
- Combined Prediction Score: 0.7646322247076736
- Mean Citation Score: 281.938596
- Max Citation Score: 288.99008
- Similarity Product: 195.3737954991149

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test